Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is a study protocol describing a planned RCT that has not yet reported results; it presents the design and intended analysis but no outcome data, making it a prospective registration document rather than a completed trial.
Preclinical in vitro and xenograft study proposing a mechanism by which an existing drug may enhance chemotherapy, without clinical efficacy data or human evidence.
V M Bekhterev Review of Psychiatry and Medical Psychology
A descriptive survey of clinician opinions and practices regarding anhedonia management, without comparative data, control groups, or validated clinical outcomes; represents clinicians' subjective views rather than empirical evidence of effectiveness.
The International Journal of Neuropsychopharmacology
A consensus-based presentation of operational criteria for TRD and PRD, combined with a review of biological mechanisms and trial design innovations, intended to standardize definitions and inform future clinical research rather than report a primary empirical finding.
A structured narrative review synthesizing methodological and regulatory challenges across ketamine and psilocybin trials, identifying systemic weaknesses in trial design and implementation readiness rather than reporting a primary efficacy result.
The International Journal of Neuropsychopharmacology
A sound cross-sectional study with pre-specified biomarker hypotheses and ROC analysis showing female-specific IL-6 and CRP associations with MDD in obesity, but limited by small sample size, single setting, and lack of longitudinal or independent validation.
A single-centre, quasi-experimental comparison showing superiority of vilazodone over escitalopram on depression severity, but limited by single-blind design, lack of active comparator control, and modest sample size without prespecified primary endpoints.